127 related articles for article (PubMed ID: 33246171)
21. Andrographolide inhibits HMGB1-induced inflammatory responses in human umbilical vein endothelial cells and in murine polymicrobial sepsis.
Lee W; Ku S; Yoo H; Song K; Bae J
Acta Physiol (Oxf); 2014 May; 211(1):176-87. PubMed ID: 24581270
[TBL] [Abstract][Full Text] [Related]
22. Orientin inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis.
Yoo H; Ku SK; Lee T; Bae JS
Inflammation; 2014 Oct; 37(5):1705-17. PubMed ID: 24771074
[TBL] [Abstract][Full Text] [Related]
23. Vascular barrier protective effects of baicalin, baicalein and wogonin in vitro and in vivo.
Kwak S; Ku SK; Han MS; Bae JS
Toxicol Appl Pharmacol; 2014 Nov; 281(1):30-8. PubMed ID: 25223693
[TBL] [Abstract][Full Text] [Related]
24. Exendin-4 inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis.
Lee W; Ku SK; Park EJ; Na DH; Kim KM; Bae JS
Inflammation; 2014 Oct; 37(5):1876-88. PubMed ID: 24826914
[TBL] [Abstract][Full Text] [Related]
25. Vascular barrier protective effects of piperlonguminine in vitro and in vivo.
Ku SK; Kim JA; Bae JS
Inflamm Res; 2014 May; 63(5):369-79. PubMed ID: 24468889
[TBL] [Abstract][Full Text] [Related]
26. Methylthiouracil, a new treatment option for sepsis.
Kwak S; Ku SK; Kang H; Baek MC; Bae JS
Vascul Pharmacol; 2017 Jan; 88():1-10. PubMed ID: 26239884
[TBL] [Abstract][Full Text] [Related]
27. Anti-inflammatory activities of isorhamnetin-3-O-galactoside against HMGB1-induced inflammatory responses in both HUVECs and CLP-induced septic mice.
Kim TH; Ku SK; Bae JS
J Cell Biochem; 2013 Feb; 114(2):336-45. PubMed ID: 22930571
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of epi-sesamin on HMGB1-induced vascular barrier disruptive responses in vitro and in vivo.
Lee W; Ku SK; Kim JA; Lee T; Bae JS
Toxicol Appl Pharmacol; 2013 Mar; 267(3):201-8. PubMed ID: 23352503
[TBL] [Abstract][Full Text] [Related]
29. Emodin alleviates sepsis-mediated lung injury via inhibition and reduction of NF-kB and HMGB1 pathways mediated by SIRT1.
Liu FJ; Gu TJ; Wei DY
Kaohsiung J Med Sci; 2022 Mar; 38(3):253-260. PubMed ID: 34806822
[TBL] [Abstract][Full Text] [Related]
30. β-Catenin phosphorylation at Y654 and Y142 is crucial for high mobility group box-1 protein-induced pulmonary vascular hyperpermeability.
Weng J; Yu L; Chen Z; Su H; Yu S; Zhang Y; Lei X; Chen L; Cui Y; Huang Q; Jiang Y; Guo X
J Mol Cell Cardiol; 2019 Feb; 127():174-184. PubMed ID: 30592964
[TBL] [Abstract][Full Text] [Related]
31. Ameliorative effect of a rarely occurring C-methylrotenoid on HMGB1-induced septic responses in vitro and in vivo.
Yang EJ; Lee W; Song KS; Bae JS
Biochem Pharmacol; 2016 Jun; 110-111():58-70. PubMed ID: 27106082
[TBL] [Abstract][Full Text] [Related]
32. A dual-role of Gu-4 in suppressing HMGB1 secretion and blocking HMGB1 pro-inflammatory activity during inflammation.
Zhou H; Ji X; Wu Y; Xuan J; Qi Z; Shen L; Lan L; Li Q; Yin Z; Li Z; Zhao Z
PLoS One; 2014; 9(3):e89634. PubMed ID: 24603876
[TBL] [Abstract][Full Text] [Related]
33. Antiseptic Effects of New 3'-N-Substituted Carbazole Derivatives In Vitro and In Vivo.
Lee W; Kwak S; Yun E; Lee JH; Na M; Song GY; Bae JS
Inflammation; 2015 Aug; 38(4):1649-61. PubMed ID: 25743565
[TBL] [Abstract][Full Text] [Related]
34. Role of moesin in HMGB1-stimulated severe inflammatory responses.
Lee W; Kwon OK; Han MS; Lee YM; Kim SW; Kim KM; Lee T; Lee S; Bae JS
Thromb Haemost; 2015 Aug; 114(2):350-63. PubMed ID: 25947626
[TBL] [Abstract][Full Text] [Related]
35. Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models.
Lee W; Kim TH; Ku SK; Min KJ; Lee HS; Kwon TK; Bae JS
Toxicol Appl Pharmacol; 2012 Jul; 262(1):91-8. PubMed ID: 22561332
[TBL] [Abstract][Full Text] [Related]
36. Salidroside ameliorates sepsis-induced acute lung injury and mortality via downregulating NF-κB and HMGB1 pathways through the upregulation of SIRT1.
Lan KC; Chao SC; Wu HY; Chiang CL; Wang CC; Liu SH; Weng TI
Sci Rep; 2017 Sep; 7(1):12026. PubMed ID: 28931916
[TBL] [Abstract][Full Text] [Related]
37. Ketamine inhibits LPS-induced HGMB1 release in vitro and in vivo.
Zhang Z; Zhang L; Zhou C; Wu H
Int Immunopharmacol; 2014 Nov; 23(1):14-26. PubMed ID: 25133650
[TBL] [Abstract][Full Text] [Related]
38. β₁-adrenergic receptor-mediated HO-1 induction, via PI3K and p38 MAPK, by isoproterenol in RAW 264.7 cells leads to inhibition of HMGB1 release in LPS-activated RAW 264.7 cells and increases in survival rate of CLP-induced septic mice.
Ha YM; Ham SA; Kim YM; Lee YS; Kim HJ; Seo HG; Lee JH; Park MK; Chang KC
Biochem Pharmacol; 2011 Oct; 82(7):769-77. PubMed ID: 21763292
[TBL] [Abstract][Full Text] [Related]
39. Ameliorative Effect of Vicenin-2 and Scolymoside on TGFBIp-Induced Septic Responses.
Lee W; Ku SK; Bae JS
Inflammation; 2015 Dec; 38(6):2166-77. PubMed ID: 26084452
[TBL] [Abstract][Full Text] [Related]
40. Anti-Inflammatory Effects of Lysozyme Against HMGB1 in Human Endothelial Cells and in Mice.
Lee W; Ku SK; Na DH; Bae JS
Inflammation; 2015 Oct; 38(5):1911-24. PubMed ID: 25899805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
